Category: Nasdaq:RAPP

BOSTON and SAN DIEGO, Sept. 09, 2025 (GLOBE NEWSWIRE) — Rapport Therapeutics, Inc. (Nasdaq: RAPP) (“Rapport” or the “Company”), a clinical-stage biotechnology company dedicated to…